{"schema_version":"secwatch.filing_event.v1","accession":"0001000753-24-000043","form_type":"8-K","ticker":"NSP","cik":"0001000753","company_name":"INSPERITY, INC.","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.826291+00:00","generated_at":"2026-05-31T13:34:59.623493+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Insperity Q2 adjusted EPS $0.86 (+34% YoY); revenue $1.6B (+1%)","bullets":["Q2 net income $18M, diluted EPS $0.48; adjusted EPS $0.86, adjusted EBITDA $66M (+29% YoY).","Revenue $1.6B (+1%) on 3% higher rev/WSEE, offsetting 1% drop in paid WSEEs to 306,958.","Gross profit $260M (+16%) on improved pricing and lower benefits costs vs prior-year healthcare spike.","H1 2024 adjusted EPS $3.13, adjusted EBITDA $208M; $81M returned via buybacks ($37M) and dividends ($44M).","Updated FY2024 guidance issued; Q3 outlook provided in press release."],"urls":{"canonical":"https://secwatch.observer/filing/0001000753-24-000043","json":"https://secwatch.observer/filing/0001000753-24-000043.json","markdown":"https://secwatch.observer/filing/0001000753-24-000043.md","text":"https://secwatch.observer/filing/0001000753-24-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000753/000100075324000043/0001000753-24-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000753/000100075324000043/nsp-20240801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:34:59.623493+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}